T. KÖŞECİ Et Al. , "Prognostic importance of peripheral blood parameters in HER-2 positive metastatic breast cancer treated by pertuzumab, trastuzumab and docetaxel," Medical Science and Discovery , vol.8, no.12, pp.730-734, 2021
KÖŞECİ, T. Et Al. 2021. Prognostic importance of peripheral blood parameters in HER-2 positive metastatic breast cancer treated by pertuzumab, trastuzumab and docetaxel. Medical Science and Discovery , vol.8, no.12 , 730-734.
KÖŞECİ, T., OLGUN, P., ATA, S., BAYRAM, E., SUNGUR, M. A., ESER, K., ... BOZKURT DUMAN, B.(2021). Prognostic importance of peripheral blood parameters in HER-2 positive metastatic breast cancer treated by pertuzumab, trastuzumab and docetaxel. Medical Science and Discovery , vol.8, no.12, 730-734.
KÖŞECİ, TOLGA Et Al. "Prognostic importance of peripheral blood parameters in HER-2 positive metastatic breast cancer treated by pertuzumab, trastuzumab and docetaxel," Medical Science and Discovery , vol.8, no.12, 730-734, 2021
KÖŞECİ, TOLGA Et Al. "Prognostic importance of peripheral blood parameters in HER-2 positive metastatic breast cancer treated by pertuzumab, trastuzumab and docetaxel." Medical Science and Discovery , vol.8, no.12, pp.730-734, 2021
KÖŞECİ, T. Et Al. (2021) . "Prognostic importance of peripheral blood parameters in HER-2 positive metastatic breast cancer treated by pertuzumab, trastuzumab and docetaxel." Medical Science and Discovery , vol.8, no.12, pp.730-734.
@article{article, author={TOLGA KÖŞECİ Et Al. }, title={Prognostic importance of peripheral blood parameters in HER-2 positive metastatic breast cancer treated by pertuzumab, trastuzumab and docetaxel}, journal={Medical Science and Discovery}, year=2021, pages={730-734} }